Clinical Trial Update: The Effect of Ribose on B-Type Natriuretic Peptide (BNP) Levels in Congestive Heart Failure Patients [NA]

View source ↗

Summary

A terminated clinical trial evaluated whether D-ribose supplementation affects BNP levels in patients with heart failure. The sponsor was Valen Labs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• D-ribose (D-ribose)

Snippet

Sponsor: Valen Labs | Conditions: Congestive Heart Failure | NA | Status: TERMINATED